Literature DB >> 24858165

The quality of life of Sri Lankan patients with cutaneous leishmaniasis.

R R Ranawaka1, H S Weerakoon, S H de Silva.   

Abstract

The effect of cutaneous leishmaniasis on the quality of life (QoL) in Sri Lankan patients' had not been evaluated before. This study was done to identify the factors resulting poor QoL in cutaneous leishmaniasis. The standard one-week Dermatology Life Quality Index (DLQI) questionnaire was used on 146 patients. The children <15 years of age, illiterates, who could not understand the questionnaire were excluded. Twenty one percent had no effect; overall 86% had DLQI ≤10 indicating low/moderate effect. The least affected area was sexual function with some 92% stating they were not affected at all, while the areas of feelings, shopping, social, partner and treatment, (in descending order), being endorsed as the most affected areas. Facial lesions, lesions ≥25mm diameter, 21-40 age group were identified as being associated with poor QoL. Overall cutaneous leishmaniasis in Sri Lanka was a mild disease having low/moderate impact on 86% of patient's, in which 'feelings' being the most affected and 'sexual function' being the least affected domain.

Entities:  

Mesh:

Year:  2014        PMID: 24858165

Source DB:  PubMed          Journal:  Mymensingh Med J        ISSN: 1022-4742


  5 in total

1.  Cutaneous leishmaniasis in Sri Lanka: effect on quality of life.

Authors:  Wardha F Refai; Nayani P Madarasingha; Buthsiri Sumanasena; Sudath Weerasingha; Rohini Fernandopulle; Nadira D Karunaweera
Journal:  Int J Dermatol       Date:  2018-09-23       Impact factor: 2.736

2.  Assessment of psychiatric morbidity and quality of life in children and adolescents with cutaneous leishmaniasis and their parents.

Authors:  Enver Turan; Hasan Kandemir; Yavuz Yeşilova; Suat Ekinci; Osman Tanrıkulu; Sultan Basmacı Kandemir; Mehmet Salih Gurel
Journal:  Postepy Dermatol Alergol       Date:  2015-10-29       Impact factor: 1.837

3.  Development and initial validation of a cutaneous leishmaniasis impact questionnaire.

Authors:  Endi Lanza Galvão; Mariana Junqueira Pedras; Gláucia Fernandes Cota; Taynãna César Simões; Ana Rabello
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

4.  Cutaneous leishmaniasis and co-morbid major depressive disorder: A systematic review with burden estimates.

Authors:  Freddie Bailey; Karina Mondragon-Shem; Lee Rafuse Haines; Amina Olabi; Ahmed Alorfi; José Antonio Ruiz-Postigo; Jorge Alvar; Peter Hotez; Emily R Adams; Iván D Vélez; Waleed Al-Salem; Julian Eaton; Álvaro Acosta-Serrano; David H Molyneux
Journal:  PLoS Negl Trop Dis       Date:  2019-02-25

5.  How cutaneous leishmaniasis and treatment impacts in the patients' lives: A cross-sectional study.

Authors:  Endi Lanza Galvão; Mariana Junqueira Pedras; Gláucia Fernandes Cota; Ana Rabello; Taynãna César Simões
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.